Compare Sinergi Megah Internusa Tbk. (NUSA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinergi Megah Internusa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sinergi Megah Internusa Tbk. trades at Rp50 (market cap 385B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Sinergi Megah Internusa Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| NUSA | OBAT | |
|---|---|---|
Market Cap | 385B | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinergi Megah Internusa Tbk.
PT Sinergi Megah Internusa Tbk (the Company) was established based on Notarial Deed No. 50 of Mustofa, S.H., M.Kn, dated May 30, 2014.
Read more on NUSA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
